Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases.
paper
Cited
Public
Unavailable
- Authors
- Kamendulis, L M; Brzezinski, M R; Pindel, E V; Bosron, W F; Dean, R A
- Year
- 1996
- Journal
- The Journal of pharmacology and experimental therapeutics
- PMID
- 8930175
Concomitant i.v. use of cocaine and heroin ("speedballing") is prevalent among drug-abusing populations. Heroin is rapidly metabolized by sequential deacetylation of two separate ester bonds to yield 6-monoacetylmorphine and morphine. Hydrolysis of heroin to 6-monoacetylmorphine is catalyzed by pseudocholinesterase. The pathway for hydrolysis of 6-monoacetylmorphine to morphine in vivo has yet to be established. Pseudocholinesterase and two human liver carboxylesterases [human liver carboxylesterase form 1 (hCE-1) and human liver carboxylesterase form 2 (hCE-2)] catalyze the rapid hydrolysis of ester linkages in cocaine. This investigation examined the relative catalytic efficiencies of hCE-1, hCE-2 and pseudocholinesterase for heroin metabolism and compared them with cocaine hydrolysis. Enzymatic formation of 6-monoacetylmorphine and morphine was determined by reverse-phase high-performance liquid chromatography. All three enzymes rapidly catalyzed hydrolysis of heroin to 6-monoacetylmorphine (hCE-1 kcat = 439 min-1, hCE-2 kcat = 2186 min-1 and pseudocholinesterase kcat = 13 min-1). The catalytic efficiency, under first-order conditions, for hCE-2-catalyzed formation of 6-monoacetylmorphine (314 min-1 mM-1) was much greater than that for either hCE-1 or pseudocholinesterase (69 and 4 min-1 mM-1, respectively). Similarly, the catalytic efficiency for hydrolysis of 6-monoacetylmorphine to morphine by hCE-2 (22 min-1 mM-1) was substantially greater than that for hCE-1 (0.024 min-1 mM-1). Cocaine competitively inhibited hCE-1-, hCE-2- and pseudocholinesterase-catalyzed hydrolysis of heroin to 6-monoacetylmorphine (Ki = 530, 460 and 130 microM, respectively) and 6-monoacetylmorphine hydrolysis to morphine (Ki = 710, 220 and 830 microM, respectively). These data demonstrate that metabolism of cocaine and heroin in humans is mediated by common metabolic pathways. The role of hepatic hCE-2 is particularly important for the hydrolysis of heroin to 6-monoacetylmorphine and of 6-monoacetylmorphine to morphine.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestry. | 2017 | 28070124 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Design and synthesis of carbamate-linked ester prodrugs selectively activated by carboxylesterase 1 with enhanced stability against intestinal hydrolysis. | Takahashi M et al. | β | 2026 | β |
| Biochemical and Functional Characterization of <i>E. coli</i> Aminopeptidase N: A New Role as a 6-Monoacetylmorphine Hydrolase. | Chen X et al. | β | 2025 | β |
| Carboxylesterase 1-mediated endocannabinoid metabolism in skin: role in melanoma progression in BRaf<sup>V600E</sup>/Pten<sup>-/-</sup> mice. | Morozova V et al. | β | 2025 | β |
| Enzymatic hydrolysis of β<sup>8</sup>-THC-O, β<sup>9</sup>-THC-O, 11-Ξ±-HHC-O, and 11-Ξ²-HHC-O by pooled human liver microsomes to generate β<sup>8</sup>-THC, β<sup>9</sup>-THC, 11-Ξ±-HHC, and 11-Ξ²-HHC. | Zhao S et al. | β | 2025 | β |
| Explaining the high mortality among opioid-cocaine co-users compared to opioid-only users. A systematic review. | van Amsterdam J et al. | β | 2025 | β |
| A quantitative LC-MS/MS method for investigation of polysubstance use involving heroin and cocaine. | Wei H et al. | β | 2024 | β |
| In vitro and in vivo stability of a highly efficient long-acting cocaine hydrolase. | Shang L et al. | β | 2024 | β |
| Heroin and its metabolites: relevance to heroin use disorder. | Milella MS et al. | β | 2023 | β |
| Kinetic characterization of an efficient cocaine hydrolase against toxic metabolites of cocaine. | Zhan M et al. | β | 2023 | β |
| Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations. | Marton J et al. | β | 2022 | β |
| Systematically Modulating Aptamer Affinity and Specificity by Guanosine-to-Inosine Substitution. | Manuel BA et al. | β | 2022 | β |
| Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene. | Liu J et al. | β | 2021 | β |
| Electromembrane Extraction and Mass Spectrometry for Liver Organoid Drug Metabolism Studies. | Skottvoll FS et al. | β | 2021 | β |
| Human carboxylesterases and fluorescent probes to image their activity in live cells. | Singh A et al. | β | 2021 | β |
| Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations. | Tanna RS et al. | β | 2021 | β |
| Adverse pharmacokinetic interactions between illicit substances and clinical drugs. | Abbott KL et al. | β | 2020 | β |
| Catalytic activities of cocaine hydrolases against the most toxic cocaine metabolite norcocaethylene. | Zheng X et al. | β | 2020 | β |
| Electromembrane extraction and mass spectrometry for liver organoid drug metabolism studies | Skottvoll FS et al. | β | 2020 | β |
| Investigation of the chiral recognition ability of human carboxylesterase 1 using indomethacin esters. | Takahashi M et al. | β | 2020 | β |
| Is genetic variability in carboxylesterase-1 and carboxylesterase-2 drug metabolism an important component of personalized medicine? | Laizure SC et al. | β | 2020 | β |
| Structure-activity relationship of atorvastatin derivatives for metabolic activation by hydrolases. | Mizoi K et al. | β | 2020 | β |
| Metabolism and metabolomics of opiates: A long way of forensic implications to unravel. | Dinis-Oliveira RJ | β | 2019 | β |
| PEGylation but Not Fc-Fusion Improves in Vivo Residence Time of a Thermostable Mutant of Bacterial Cocaine Esterase. | Huang H et al. | β | 2019 | β |
| Placental trophoblast transfer of opioids following exposures to individual or mixtures of opioids <i>in vitro</i>. | Mortensen NP et al. | β | 2019 | β |
| Blocking drug activation as a therapeutic strategy to attenuate acute toxicity and physiological effects of heroin. | Zhang T et al. | β | 2018 | β |
| Confirmation of recent heroin abuse: Accepting the challenge. | Maas A et al. | β | 2018 | β |
| Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality. | Hwang CS et al. | β | 2018 | β |
| Extracellular esterase activity as an indicator of endoplasmic reticulum calcium depletion. | Trychta KA et al. | β | 2018 | β |
| Kinetic characterization of cholinesterases and a therapeutically valuable cocaine hydrolase for their catalytic activities against heroin and its metabolite 6-monoacetylmorphine. | Kim K et al. | β | 2018 | β |
| Presence of Parent Cocaine in the Absence of Benzoylecgonine in Urine. | Puet BL et al. | β | 2018 | β |
| Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants. | Boberg M et al. | β | 2017 | β |
| An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestry. | Meyers JL et al. | β | 2017 | β |
| The novel nematicide wact-86 interacts with aldicarb to kill nematodes. | Burns AR et al. | β | 2017 | β |
| Carriers of genetic variants in the HNF1A gene are more common among dead opioid addicts than among living addicts. | Nguyen A et al. | β | 2016 | β |
| Cysteine Metabolism and Oxidative Processes in the Rat Liver and Kidney after Acute and Repeated Cocaine Treatment. | Kowalczyk-Pachel D et al. | β | 2016 | β |
| Synthesis and evaluation of atorvastatin esters as prodrugs metabolically activated by human carboxylesterases. | Mizoi K et al. | β | 2016 | β |
| Effects of alcohol on human carboxylesterase drug metabolism. | Parker RB et al. | β | 2015 | β |
| Kinetic characterization of a cocaine hydrolase engineered from mouse butyrylcholinesterase. | Chen X et al. | β | 2015 | β |
| Amino-acid mutations to extend the biological half-life of a therapeutically valuable mutant of human butyrylcholinesterase. | Fang L et al. | β | 2014 | β |
| A model of glycosylated human butyrylcholinesterase. | Fang L et al. | β | 2014 | β |
| In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors. | Thomsen R et al. | β | 2014 | β |
| In vitro hydrolysis and transesterification of CDP323, an Ξ±4Ξ²1/Ξ±4Ξ²7 integrin antagonist ester prodrug. | Chanteux H et al. | β | 2014 | β |
| Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine. | Zhan M et al. | β | 2014 | β |
| Kinetic characterization of human butyrylcholinesterase mutants for the hydrolysis of cocaethylene. | Hou S et al. | β | 2014 | β |
| Pharmacokinetic interactions between ethanol and heroin: a study on post-mortem cases. | Thaulow CH et al. | β | 2014 | β |
| Prevalence of heroin markers in urine for pain management patients. | Knight J et al. | β | 2014 | β |
| Rational design, preparation, and characterization of a therapeutic enzyme mutant with improved stability and function for cocaine detoxification. | Fang L et al. | β | 2014 | β |
| Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine. | Qiao Y et al. | β | 2014 | β |
| The interference of ethanol with heroin-stimulated psychomotor activation in mice is not related to changed brain concentrations of the active metabolites 6MAM or morphine. | Andersen JM et al. | β | 2014 | β |
| Vaccines against stimulants: cocaine and MA. | Kosten T et al. | β | 2014 | β |
| Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes. | NegrΓ£o AB et al. | β | 2013 | β |
| Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine. | Xue L et al. | β | 2013 | β |
| Evaluation of intestinal absorption of amtolmetin guacyl in rats: breast cancer resistant protein as a primary barrier of oral bioavailability. | Rong Z et al. | β | 2013 | β |
| Fundamental reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of heroin. | Qiao Y et al. | β | 2013 | β |
| Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice. | Boix F et al. | β | 2013 | β |
| Substrate selectivity of high-activity mutants of human butyrylcholinesterase. | Hou S et al. | β | 2013 | β |
| The role of human carboxylesterases in drug metabolism: have we overlooked their importance? | Laizure SC et al. | β | 2013 | β |
| Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users. | Munshaw S et al. | β | 2012 | β |
| PolyMorphine: an innovative biodegradable polymer drug for extended pain relief. | Rosario-MelΓ©ndez R et al. | β | 2012 | β |
| Validation of a gas chromatography-ion trap-tandem mass spectrometry assay for the simultaneous quantification of cocaine, benzoylecgonine, cocaethylene, morphine, codeine, and 6-acetylmorphine in aqueous solution, blood, and skeletal muscle tissue. | Rees KA et al. | β | 2012 | β |
| Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. | Meyer MR et al. | β | 2011 | β |
| Carboxylesterase inhibitors. | Hatfield MJ et al. | β | 2011 | β |
| Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. | Xue L et al. | β | 2011 | β |
| Developing a vaccine against multiple psychoactive targets: a case study of heroin. | Stowe GN et al. | β | 2011 | β |
| Screening for drugs of abuse: which matrix, oral fluid or urine? | Allen KR | β | 2011 | β |
| Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin. | Hatfield MJ et al. | β | 2010 | β |
| Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine. | Yang W et al. | β | 2010 | β |
| Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency. | Zheng F et al. | β | 2010 | β |
| Free energy perturbation simulation on transition states and high-activity mutants of human butyrylcholinesterase for (-)-cocaine hydrolysis. | Yang W et al. | β | 2010 | β |
| Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity. | Yamada S et al. | β | 2010 | β |
| Novel, selective sample stacking microemulsion electrokinetic capillary chromatography induced by reverse migrating pseudostationary phase for the determination of the new ultra-short acting hypnotic "HIE-124" in mice serum. | Hefnawy M et al. | β | 2010 | β |
| The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions. | Parker RB et al. | β | 2010 | β |
| Free-energy perturbation simulation on transition states and redesign of butyrylcholinesterase. | Yang W et al. | β | 2009 | β |
| Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity. | Hicks LD et al. | β | 2009 | β |
| Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo. | Andersen JM et al. | β | 2009 | β |
| Modifications of human carboxylesterase for improved prodrug activation. | Hatfield JM et al. | β | 2008 | β |
| Most efficient cocaine hydrolase designed by virtual screening of transition states. | Zheng F et al. | β | 2008 | β |
| Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. | Hosokawa M | β | 2008 | β |
| Synthesis, ultra-short acting hypnotic activity, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a] [1,3]diazepin-3-carboxylate (HIE-124). | Kadi AA et al. | β | 2008 | β |
| The biotransformation of prasugrel, a new thienopyridine prodrug, by the human carboxylesterases 1 and 2. | Williams ET et al. | β | 2008 | β |
| Carboxylesterase in the liver and small intestine of experimental animals and human. | Taketani M et al. | β | 2007 | β |
| Free energy perturbation (FEP) simulation on the transition states of cocaine hydrolysis catalyzed by human butyrylcholinesterase and its mutants. | Pan Y et al. | β | 2007 | β |
| Genomic structure and transcriptional regulation of the rat, mouse, and human carboxylesterase genes. | Hosokawa M et al. | β | 2007 | β |
| Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. | Bao G et al. | β | 2007 | β |
| The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue. | Mutch E et al. | β | 2007 | β |
| Characterization of pyrethroid hydrolysis by the human liver carboxylesterases hCE-1 and hCE-2. | Nishi K et al. | β | 2006 | β |
| Computational design of a human butyrylcholinesterase mutant for accelerating cocaine hydrolysis based on the transition-state simulation. | Gao D et al. | β | 2006 | β |
| Modeling evolution of hydrogen bonding and stabilization of transition states in the process of cocaine hydrolysis catalyzed by human butyrylcholinesterase. | Gao D et al. | β | 2006 | β |
| Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1. | Bencharit S et al. | β | 2006 | β |
| Mutation of F417 but not of L418 or L420 in the lipid binding domain decreases the activity of triacylglycerol hydrolase. | Alam M et al. | β | 2006 | β |
| Nucleoside ester prodrug substrate specificity of liver carboxylesterase. | Landowski CP et al. | β | 2006 | β |
| Population pharmacokinetics of heroin and its major metabolites. | Rook EJ et al. | β | 2006 | β |
| Structure, function and regulation of carboxylesterases. | Satoh T et al. | β | 2006 | β |
| Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. | Maurer HH et al. | β | 2006 | β |
| Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine. | Zhan CG et al. | β | 2005 | β |
| Computational redesign of human butyrylcholinesterase for anticocaine medication. | Pan Y et al. | β | 2005 | β |
| Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients. | Klous MG et al. | β | 2005 | β |
| Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats. | Solinas M et al. | β | 2005 | β |
| Mammalian carboxylesterases: from drug targets to protein therapeutics. | Redinbo MR et al. | β | 2005 | β |
| Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants. | Hamza A et al. | β | 2005 | β |
| Pharmaceutical heroin for inhalation: thermal analysis and recovery experiments after volatilisation. | Klous MG et al. | β | 2005 | β |
| Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. | Kreek MJ et al. | β | 2005 | β |
| The role of cocaine in heroin-related deaths. Hypothesis on the interaction between heroin and cocaine. | Polettini A et al. | β | 2005 | β |
| Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species. | Kovacic P et al. | β | 2005 | β |
| Opioid partial agonist effects of 3-O-methylnaltrexone in rhesus monkeys. | Platt DM et al. | β | 2004 | β |
| Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. | Laizure SC et al. | β | 2003 | β |
| Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition. | Bencharit S et al. | β | 2003 | β |
| Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase. | Zhan CG et al. | β | 2003 | β |
| Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. | Bencharit S et al. | β | 2003 | β |
| Current progress on esterases: from molecular structure to function. | Satoh T et al. | β | 2002 | β |
| Interactions between recreational drugs and antiretroviral agents. | Antoniou T et al. | β | 2002 | β |
| mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. | Selley DE et al. | β | 2001 | β |
| Metabolism of drugs of abuse by cytochromes P450. | Cho AK et al. | β | 1999 | β |
| Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. | Gorelick DA | β | 1997 | β |
| Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. | Pindel EV et al. | β | 1997 | β |